Accurate quantitation of local glucose meta bolic rates (LMRglc) of abnormal tissues such as brain tumors with the 2-deoxyglucose (DG) method requires knowledge of the tissue rate constants and lumped con stant. The deoxyglucose rate constants were measured in an experimental intracerebral glioma in 24 awake rats with a dual tracer [eH)-DG and e4C)-DG] method. Tis sue time points were obtained at 2, 5, 10, 18, 30, 60, 90, and 180 min after injection by decapitation and liquid scintillation counting. Blood samples were obtained at 1 min intervals initially and at longer intervals later. The rate constants were estimated with parameter estimation. LMRglc was calculated from the rate constants, assuming Regional glucose metabolic rates in brain can be quantified by means of the 2-deoxyglucose (D G) ap proach with quantitative autoradiography (QAR) (Sokoloff et aI. , 1977) or positron emission tomog raphy (PET) (Phelps et aI. , 1979). This method is based on a three-compartment model and an oper ational equation that contains kinetic rate constants for the exchange of DG across the blood-brain bar rier and through the hexokinase reaction to deoxy glucose-6-phosphate where it is trapped, and a lumped constant that is the ratio of the utilization of deoxyglucose to that of glucose. The use of the DG method to measure the regional glucose metabolic rate in pathologic tissue such as brain tumors is problematic because the values of the kinetic rate constants and the lumped constant (LC) derived from normal tissue probably differ from the values of these parameters in diseased tissue (Crane et aI.,
a lumped constant of 0.5. K I for normal cerebrum was found to be 0.258 mUg/min, and k 2-k 4 were 0.406, 0.075, and 0.0103 min-I ; LMRglc = 65.1ILmoUl00 g/min. The corresponding values for the glioma were 0.108, 0.126, 0.040, and 0.0019 with LMRglc = 41.7. The considerably lower k 4 in the glioma was reflected in persistent higher activity in the glioma at longer times. Thus, tissue activity alone cannot be used to assess relative glucose metabolic rates in abnormal tissues such as gliomas, particularly at late times after injection. Key Words: Brain tumors Cerebral glucose metabolic rate-Dual isotope-CH) deoxyglucose-(14C)-deoxyglucose. Kato et aI. , 1985; Phelps et aI. , 1979; Sokoloff et aI. , 1977) . This paper reports estimates of the kinetic rate constants in an intracerebrally trans planted rat glioma model. A comparison between the rate constants in normal brain and tumor tissue and their influence on the calculated glucose meta bolic rate for the tumor is presented. MO, U.S.A.) . Radiolabeled deoxygiucose was de termined to be more than 98% radiochemically pure using TLC, HPLC, and enzymatic analysis prior to use. The 1251 albumin was passed through a PD-IO gel filtration column (Pharmacia, Piscataway, NJ) immediately prior to injection to remove any free 1251. Soluene-350 and In stagel liquid scintillant were purchased from Packard In strument Co. (Downers Grove, IL) .
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METHODS Chemicals
Rat brain tumor model
The rat brain tumor model used in this work has been reported in detail (Geraci and Spence, 1979; Spence and Coates, 1978; . Briefly, 5 x 104 viable cells from in vitro stocks of an ethylnitrosourea-induced F-344 rat as trocytic glioma numbered 36B-1O were transplanted into the right cerebral hemisphere of syngeneic females weigh ing 140 to 180 gms (Simonsen Laboratories, Gilroy, CA). The exact stereotaxic injection coordinates were: 6 mm deep, 3 mm to the right of the midline, and 4.5 mm ante rior to the frontal zero plane (Barker et aI., 1973; Konig and Klippel, 1963) . Untreated animals generally survive 18 to 25 days and then succumb to the mass effects of intracranial focal tumor expansion.
Animal preparation
Twenty-four rats, bearing 19 day-old implants weighing 50-80 milligrams, were used for this work. One day be fore study, under pentobarbital anesthesia (20 mg/kg, in traperitoneally), polyethylene catheters were placed into the aorta via the femoral artery and into the vena cava via the femoral vein. These catheters were tunneled subcu taneously and brought out at the base of the rat's neck posteriorly. Following this the rats were allowed to awaken. The studies were conducted 18-20 hours later. During this period the animals were supplied with water but not with food.
Deoxyglucose kinetic studies
The usual approach to the measurement of rate con stants of deoxyglucose in a tissue such as brain tumor is to inject many rats with e4C)-DG, sample arterial blood, and kill the rats at several different times for tissue sam ples. This yields tissue activity at a single point in time for each animal. By using eH)-DG and e4C)-DG, injected at different times, we were able to obtain two tissue time points in each animal, thus halving the necessary number of experiments.
One day after catheterization, the rats were placed on a platform where they could hide their heads in a dark box. This arrangement effectively immobilized the animals and minimized the amount of stress. The arterial catheter was attached to a semiautomatic blood sampler (Graham, 1971) while the venous catheter was used for injection of radioactive DG. Plasma samples, obtained via the arterial catheter just prior to injection of radioisotopes and 1-2 min before animal killing, were analyzed for glucose con tent with a Beckman Glucose Analyzer II (Beckman In struments Company, Fullerton, CA, U.S.A.).
Either 5 IJ-Ci of e4C)-DG or 50 IJ-Ci of eH)-DG was injected as a bolus in 0.1 ml normal saline, followed by a 0.2-0.3 ml heparinized saline flush. Arterial blood sam ples were collected at I-min intervals initially and at longer intervals later. The other form of DG was injected later and was also followed by blood sampling at 1 min intervals initially. By injecting each animal first with one labeled form of DG (e.g., 3 H) and then later with the other labeled form (e.g., ] 4C), we were able to collect from each rat two plasma DG time-activity curves and two tumor and normal brain labeled DG concentrations. The injec tion sequence of first eH)-DG and then e4C)-DG was alternated. Seven animals were studied at the 2 and 5 min points, seven at 10 and 18 min, six at 30 and 60 min, and four at 90 and 180 min. The animals were not anesthetized and were killed by rapid decapitation. This procedure was approved by the University of Washington Animal Care Committee. After decapitation, the brains were rapidly removed, frozen in Freon 12, and then stored at -70°C until they could be sampled for tissue liquid scintillation counting. The brain regions sampled were the glioma, J Cereb Blood Flow Metab, Vol, 9, No, 3, 1989 anterior left cerebral hemisphere (normal whole brain), cerebellum, and brainstem. These were weighed, solubi lized, and counted in InstageI. Blood samples were cen trifuged and 20 IJ-l of plasma were pipetted into a liquid scintillation vial for counting in Instagel as above,
Tissue plasma volumes
The tumor-bearing rats were prepared with catheters the day before as described above. The studies were con ducted in awake animals sitting with their heads in a dark box. (125I)-human serum albumin (1 IJ-Ci) was injected intravenously via the femoral venous catheter. Approxi mately 10 min after injection, an arterial blood sample was taken and the rat was decapitated, The brain was rapidly removed, appropriate portions were placed in pre weighed test tubes for weighing, and then counted with a Packard gamma counter. Plasma samples (100 IJ-I) were also counted. Tissue plasma volume was calculated by dividing the counts per gram of tissue by the counts per ml of plasma.
Data analysis
The plasma time-activity curves were all normalized to 100 at the 1 min sample time and the tissue activity was normalized accordingly. These were used as the input function in the four-parameter version of Sokoloff's model (Phelps et aI., 1979) , which was fit to the tissue data using a steepest descent parameter optimization method. The numeric solution of the model was calcu lated with 1 min time steps, using Euler integration. The zero time plasma activity was assumed to be equal to the 1 min activity. The rate constants and the local glucose metabolic rate (LMRglc) were determined for each tissue.
The optimizations were carried out with and without inclusion of the measured plasma volumes and included tissue time points to 60 or 180 min. The values obtained from the complete set of tissue data out to and including 180 min plus the measured plasma volume probably rep resent the most accurate estimate of the parameters. The other optimizations, at 60 min, were carried out to ap proximate the widely used Sokoloff method, which relies on tissue data obtained at 45 min (Sokoloff et aI., 1977) . A value of 0.5 was assumed for the lumped constant. Fi nally, glucose metabolic rates were calculated at 60 min with Sokoloff's operational equation and with Phelps' op erational equation and either the measured rate constants (those obtained from the 180 min optimization including plasma volume) or the mean grey or white matter K's from the literature (K ] -k 3 from Sokoloff et aI., 1977) . The measured k 4 was used with the Phelps equation since there are few other estimates of k 4 for normal rat brain.
RESULTS
The normalized 2-DG plasma time-activity curve is shown in The average plasma glucose concentration was 8.05 ± 1.35 mM (mean ± SD).
DISCUSSION
The rate constant and distribution volume esti mates for the normal brain regions are similar to those reported by others (Sokoloff et aI. , 1977; Fuglsang et aI. , 1986; Hargreaves et aI. , 1986 ; Las sen and Gjedde, 1983) (see Table 3 ). This supports the overall validity of our data. Earlier we measured and reported rate constants for normal brain and brain tumor, using a similar technique, but the rate constants were lower than the present results, prob ably because of a methodologic error (Graham et aI. , 1983) . The problem was more than a simple and, as has been shown by others (Carson et aI. , 1984; Wienhard et aI. , 1985; Hawkins et aI. , 1986; Lammertsma et aI. , 1987) , results in better fits to the data (e. g. , lower summed square error) and pre sumably more accurate estimates of the rate con stants.
Other groups have estimated rate constants in a flank tumor in the rat (Kato et aI. , 1985) and in human brain tumors (Brooks et aI. , 1984; Brooks et aI. , 1986; Hawkins et aI. , 1986; Koeppe et aI. , 1987) . The optimizations were done using data to 180 or 60 min, with or without inclusion of the measured plasma volumes (PV) for these tissues. The fit is somewhat better with PV, but it makes little difference in the parameter estimates. The 60 min optimizations were done with k4 set to zero. The units for K I are ml/g/min. All other K's are in units of min -I . The volume of distribution was calculated from KAk 2 + k3) ' The units for the volume of distribution are ml/g. The local glucose metabolic rate (LMRglc), in j.l.moI/100 glmin, was calculated from (C.,ILC) . (K 1 ' k3)/(k 2 + k3) where Cp is the plasma glucose concentration and LC is the lumped constant. LC was set equal to 0.5. Calculated with the Sokoloff operational equation (Sokoloff et aI., 1977) and with the Phelps operational equation (Phelps et al., 1979) using tissue activity at 60 min after injection of deoxyglucose. The rate constants used in the calculation were either the estimated K's, with plasma volume included, from Table I (measured) or Sokoloff's K values for grey matter (K 1 = 0.189, k2 = 0.245, k 3 = 0.052) and the estimated value for k4 (0.0103) from the present work. The lumped constant was assumed to be 0. 5. constants are multiplied by the plasma DG activity, which becomes quite small at long times after injec tion. We calculated LMRglc with both operational equations at 60 min after injection, since we did not obtain tissue activity measurements at 45 min (the standard time for Sokoloffs method). The results confirm the minimal impact that variations in the values of the rate constants have in the operational equation approach. The operational equation ap proach should not be very sensitive to the exact values of the k's used. Indeed, there is little differ ence (less than 15%) between LMRglc calculated with the operational equations using the K ' s deter mined from the kinetic data vs. using the literature values of the K ' s for grey matter. This is consistent with a similar demonstration by Kato et al. (1985) .
The results in Table 2 Part of this difference may be due to decreased blood flow to the tumor. The blood flow to this type of tumor is approximately 68% of the flow to normal hemisphere (Graham et aI., 1987; Spence et aI., 1988) . The remainder of the difference may be ex plained by less capillary surface area available for exchange per gram of tumor compared to normal brain, or the density or characteristics of the facil itated transport sites may be different in the tumor.
The phosphorylation rate constant k3 is substan tially lower in tumor than in contralateral cerebrum, but is approximately equal to the values found in cerebellum and brainstem. This presumably reflects the somewhat decreased glucose metabolic rate in the tumor compared to normal cerebrum.
The greatest difference in rate constants between tumor and normal brain is seen in k4' the dephos phorylation rate constant. k4 in tumor (0.0019 min -I ) is approximately one-fifth that of normal brain (0.0103 min -I ) . This difference is clearly ap parent from examination of the tissue time-activity curves. The 180 min activity in the glioma is ap proximately equal to the peak value, while the cor responding points in the normal tissues have fallen to 57 to 38% of the peak values. This agrees well with the results of Redies et ai. (1987) , who found a k4 value for fluorodeoxyglucose of 0.009 min -1 in normal rat brain by external coincidence detection.
The results in normal brain agree with observations of Hawkins and Miller (1978) , who found a loss rate of 0.007 to 0.01 min -1 of deoxyglucose-6-phosphate from normal rat brain.
The relatively low value of k4 in tumor implies that dephosphorylation is much less active in the tumor than in normal brain. This is surprising since it is reported by Anchors et al. (1977) that phos phatase levels are higher in extracts of several brain tumor cell lines than in normal brain. This suggests that most of the phosphatase may not be available for biochemical reaction in vivo. The practical im pact of this finding is that the operational equation methods will tend to overestimate the LMRglc in experimental tumors unless the correct rate con stants are used. Brooks et al. (1984) have estimated the FDG rate constants in human brain tumor tissue in 20 glioma bearing patients who were scanned with PET out to approximately 2 h following intravenous injection. They found the rate constants, including k4 ' in tu mor did not differ significantly from values in nor mal tissue. Brooks et ai. (1986) studied the kinetics of (lIC)-3-0-methyl-D-glucose in normal brain and in seven glioma patients and found the rate con stants were approximately the same in the tumors as in normal brain although there was an increased extraction fraction in the tumors. However, the 3-O-methylglucose method does not estimate k4. Hawkins et al. (1986) with FDG and PET have also found the rate constants KJ-k4 in primary and met astatic brain tumors to be only slightly different from normal whole brain. These results may reflect intrinsic differences between spontaneous human tumors and experimental rat brain tumors, but the error ranges in the kinetic constant estimates were substantial.
Other workers have studied glucose metabolism in human ( DiChiro et aI., 1982 ( DiChiro et aI., , 1984 and experi mental animal brain tumor systems (Blasberg et aI., 1981 (Blasberg et aI., , 1985 . DiChiro et al. (1982 DiChiro et al. ( ,1984 have shown by means of FDG/PET that high grade gliomas in humans demonstrate a "hot spot," i.e., a focus of tumor in which the glucose metabolic rate appears to be distinctly higher than in normal brain tissue. For this work, they used the modification of the operational equation of Brooks (1982) , and for their calculations in the tumors they used the LC (0.42) and KJ through k4 values (0.102, 0.130, 0.062, and 0.0068) of Huang et ai. (1980) of normal human gray matter. However, as mentioned above, in contrast to our results, these workers have found no sub stantial difference in the rate constants for tumor tissues (Brooks et aI., 1984) .
We also find relatively increased uptake ofDG by the rat brain tumor after approximately 100 min, compared to normal brain. However, because the kinetic parameters are so different, especially k4' this increased uptake does not translate into in creased metabolic rate. For the purpose of calculat ing the glucose metabolic rates in the tissues we sampled in this report, we assumed the LC equals 0.50. The LC in malignant brain tumor tissue may not be equal to the value in normal brain tissue. Kato et al. (1985) found the LC of an AA ascites flank tumor to be 0.654. Others have presented data and arguments that show that the LC is increased under conditions of hypoglycemia or ischemia, i.e., when glucose utilization is influenced more by transport limitation than by hexokinase activity (Sokoloff et aI., 1977; Crane et aI., 1983; Pardridge et aI., 1982) . Certain conditions in malignant brain tumors may yield regional hypoglycemia and/or ischemia: lower blood flow, larger extracellular spaces, greater intercapillary distances, and lack of the normal blood-brain barrier. The effect of these conditions may well shift the tumor LC to a level higher than in normal brain tissue. If this is the case, then the use of the LC of normal brain tissue to calculate the tumor glucose metabolic rate would lead to an overestimation of this metabolic rate. However, a thorough investigation of the LC, in cluding analysis of the phosphorylation kinetics of glucose and deoxyglucose in tumor tissue, must be undertaken to clarify this completely. Blasberg et al. (1981 Blasberg et al. ( ,1985 have assessed glucose metabolism in several rat glioma models. They ap plied the method of Sokoloff et al. (1977) with 2-DG and QAR. Based on the demonstration by Sokoloff et al. (1977) that the effect of rate constants be comes small at 45 min or more and assuming no dephosphorylation of 2-DG-6-P, they used a simpli fied version of the operational equation to calculate a relative glucose utilization rate that incorporates the "lumped constant." They showed convincingly that relative glucose utilization varied among the tumor models, could be heterogeneous in individual tumors, tended to be lower in larger tumor masses, and was low, as expected, in regions of tissue ne crosis. We are beginning to extend our work to pro duce the same type of e 4 C)-2-DG autoradiographs so that we can quantify the glucose metabolic rate in implanted 36B-I0 gliomas using the rate con stants we have now determined. We are measuring the LC for this transplanted tumor in order to cal culate its glucose metabolic rate as accurately as possible. Because of the present results, admittedly in an experimental brain tumor model, we raise some concern that applying normal tissue values for LC and K's to calculate glucose metabolic rate in gliomas may lead to a distinct overestimation of the true tumor glucose metabolic rate. Kato et al. (1985) have also expressed this concern and have sug gested that it may be possible to evaluate rate con stants and the lumped constants in human tumors by implantation in athymic mice.
The dual isotope deoxyglucose method described here has two major advantages over the usual single isotope study. Data collection is more rapid since two data points are obtained from each animal. Thus, a study that formerly would have taken 2 months can be accomplished in one. The other ad vantage is that the two points from a single animal can potentially be used to define the glucose meta bolic rate with greater certainty than a single point in time. Cunningham and Cremer (1981) have used a similar approach with e4C)-and eH)-deoxy glucose over a 5 min time course to define rates of glucose influx and phosphorylation. Their approach requires microwave heating of the brain and sepa ration of the metabolites. Our approach avoids the necessity for these methods by taking points at much later times. This is likely to be particularly useful in evaluating glucose metabolic rates in ab normal tissues, such as tumors, since intertumor heterogeneity can be quite marked.
